These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide.
    Author: Ehlert FJ, Roeske WR, Yamamura HI.
    Journal: J Supramol Struct; 1980; 14(2):149-62. PubMed ID: 7230804.
    Abstract:
    The regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide (NEM) was investigated using the agonist ligand, [3H] cis methyldioxolane ([3H]CD). Characterization studies on rat forebrain homogenates show that [3H]CD binding was linear with tissue concentration and was unaffected by a change in pH from 5.5 to 8.0. The regional variation in [3H]CD binding in the rat brain correlated generally wit [3H](-)3-quinuclidinyl benzilate ([3H](-)QNB) binding, although the absolute variation in binding was somewhat less. At a concentration of 100 microM, the GTP analogue, guanyl-5'-yl imidodiphosphate [Gpp(NH)p], caused a 43-77% inhibition of [3H]CD binding in the corpus striatum, ileum, and heart. The results of binding studies using several Gpp(NH)p concentrations demonstrated that the potency of this guanine nucleotide for inhibition of [3H]CD binding, Gpp(NH)p caused an increase in (3H](-)QNB binding in the heart heart and ileum and no change in [3H](-)QNB binding in the corpus striatum. When measured by competitive inhibition of [3H](-)QNB binding to the longitudinal muscle of the ileum, Gpp(NH)p (100 microM) caused an increase in the IC50 values of a series of agonists in a manner that was correlated with the efficacy of these compounds. The results of binding studies on NEM treated forebrain homogenates revealed an enhancement of [3H]CD binding by NEM.
    [Abstract] [Full Text] [Related] [New Search]